Literature DB >> 26695369

Cytoplasmic STAT4 Promotes Antiviral Type I IFN Production by Blocking CHIP-Mediated Degradation of RIG-I.

Kai Zhao1, Qian Zhang2, Xia Li1, Dezhi Zhao1, Yiqi Liu3, Qicong Shen4, Mingjin Yang5, Chunmei Wang1, Nan Li4, Xuetao Cao6.   

Abstract

Retinoic acid-inducible gene I (RIG-I) signaling is critical to host innate immune response against RNA virus infection. Numerous factors use different mechanisms to regulate RIG-I signaling. In this study, we report that STAT family member STAT4 promotes RIG-I-triggered type I IFN production in antiviral innate immunity. Silencing of STAT4 impaired IFN-β production in macrophages upon RNA virus infection, whereas overexpression of STAT4 enhanced RIG-I-induced IFN-β promoter activation and IFN-stimulated response element activity. Silencing of STAT4 increased degradation of RIG-I. Interestingly, during RNA virus infection STAT4 was found to be constantly present in cytoplasm of macrophages without Tyr(693) phosphorylation, which is required for its classical activation and nuclear translocation. Mechanistically, cytoplasmic STAT4 could interact with E3 ligase CHIP and block RIG-I and CHIP association, preventing CHIP-mediated proteasomal degradation of RIG-I via K48-linked ubiquitination. Our study provides a new manner for posttranslational regulation of RIG-I signaling and identifies a previously unknown function of cytoplasm-localized STAT4 in antiviral innate immunity.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26695369     DOI: 10.4049/jimmunol.1501224

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Multilayered regulations of RIG-I in the anti-viral signaling pathway.

Authors:  Nari Kim; Hesung Now; Nhung T H Nguyen; Joo-Yeon Yoo
Journal:  J Microbiol       Date:  2016-08-31       Impact factor: 3.422

2.  LRRC25 inhibits type I IFN signaling by targeting ISG15-associated RIG-I for autophagic degradation.

Authors:  Yang Du; Tianhao Duan; Yanchun Feng; Qingxiang Liu; Meng Lin; Jun Cui; Rong-Fu Wang
Journal:  EMBO J       Date:  2017-12-29       Impact factor: 11.598

Review 3.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

Review 4.  Regulation of cGAS- and RLR-mediated immunity to nucleic acids.

Authors:  Andrea Ablasser; Sun Hur
Journal:  Nat Immunol       Date:  2019-12-09       Impact factor: 25.606

Review 5.  Conserved and Unique Roles of Chaperone-Dependent E3 Ubiquitin Ligase CHIP in Plants.

Authors:  Yan Zhang; Gengshou Xia; Qianggen Zhu
Journal:  Front Plant Sci       Date:  2021-07-09       Impact factor: 5.753

Review 6.  Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.

Authors:  Yuchen Nan; Chunyan Wu; Yan-Jin Zhang
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

7.  MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation.

Authors:  Peipei Zhou; Xiaodan Ding; Xiaoling Wan; Lulu Liu; Xiujie Yuan; Wei Zhang; Xinhui Hui; Guangxun Meng; Hui Xiao; Bin Li; Jin Zhong; Fajian Hou; Lihwen Deng; Yan Zhang
Journal:  Nat Commun       Date:  2018-03-28       Impact factor: 14.919

8.  Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.

Authors:  Lang Yoo; A-Rum Yoon; Chae-Ok Yun; Kwang Chul Chung
Journal:  Cell Death Dis       Date:  2018-01-24       Impact factor: 8.469

Review 9.  Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like Molecules.

Authors:  Kang Li; Bo Zhong
Journal:  Immune Netw       Date:  2018-02-06       Impact factor: 6.303

10.  Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses.

Authors:  Qingxiang Liu; Yaoxing Wu; Yunfei Qin; Jiajia Hu; Weihong Xie; F Xiao-Feng Qin; Jun Cui
Journal:  Sci Adv       Date:  2018-05-02       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.